Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2007

View Archived Issues

Natural toxin shows potential against prostate cancer in vitro

New agents for treating acne and alopecia reported in recent Pfizer patent

Recent patents describe novel therapeutic agents for respiratory disorders

Novel treatment option for irritable bowel syndrome disclosed by Astellas

Identification of c-Src protein kinase inhibitors as a novel class for anti-dengue virus therapy

Anti-ribosomal P antibodies may explain CNS symptoms in SLE

Aeterna Zentaris rounds up 2006 clinical progress

Formulation work required for CRD-5 following phase I/II findings

Peplin updates progress of PEP-005 Topical program

Studies show Radilex may stimulate hematopoietic stem cells

TM-30339 advanced into clinical trials for obesity

Positive data reported from phase Ib study of TASQ

Oxford BioMedica to acquire Oxxon Therapeutics

Schering-Plough to acquire Organon Biosciences

Sym-001, first recombinant polyclonal antibody to enter clinical trials

Array BioPharma reports on anticancer activity of its p38 MAPK inhibitor

Biomarker studies test AZD-0530's potential in managing bone metastasis

Cardium Therapeutics closes private placement financing

FDA updates safety information for erythropoiesis-stimulating agents

Pemetrexed combinations found highly effective against NSCLC cells

SNS-314 shows consistent and dose-dependent antitumor activity in mice

WX-671 plus 5-FU, gemcitabine or irinotecan reduce cancer metastasis and invasion

Nitoman launched in Germany

Xyrem approved in E.U. for narcolepsy with cataplexy

Approvable letter for Accretropin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...